(R)-4-(2-bromo-1-(2-methoxyphenyl)ethoxy)tetrahydro-2H-pyran, 98%, 5g

3-Chloro-5-(trifluoromethyl)pyrazine-2-carbonitrile, 97%, 250mg

2-(furan-2-yl)-5-(piperidin-3-yl)-1,3,4-oxadiazole, 95.0%, 500mg

4-Benzoyl-3-hydroxyphenyl methacrylate, 95+%, 5g

rac-(1R,2S,4S)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, 95.0%, 1g

5-Methyl-1-phenyl-1H-pyrazole-4-carbaldehyde, 99.0%, 1g

1-(4-(Trifluoromethyl)phenyl)cyclopropanamine, 95.0%, 100mg

2,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazole-3-carbonitrile dihydrochloride, 97%, 100mg

2,2,3,3-Tetramethylcyclopropanecarboxylic acid, 97.0%, 100g

6-(Benzyloxy)-2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96%, 100mg

Barium hydroxide octahydrate, min. 98%, pa, ACS, ISO, 500 g, plastic packaging.

7-epi-Taxol, 100mg

4-Bromo-1-methyl-1H-pyrazole-5-carbaldehyde, 97.0%, 25g